2,402
Views
32
CrossRef citations to date
0
Altmetric
Radiotherapy

Pulmonary damage in Hodgkin's lymphoma patients treated with sequential chemo-radiotherapy: Predictors of radiation-induced lung injury

, , , , , , , , & show all
Pages 613-619 | Received 11 Jul 2013, Accepted 26 Sep 2013, Published online: 06 Nov 2013

References

  • Froudarakis M, Hatzimichael E, Kyriazopoulou L, Lagos K, Pappas P, Tzakos AG, et al. Revisiting bleomycin from pathophysiology to safe clinical use. Crit Rev Oncol Hematol 2013;87:90–100.
  • Marks LB, Bentzen SM, Deasy JO, Kong FM, Bradley JD, Vogelius IS, et al. Radiation dose-volume effects in the lung. Int J Radiat Oncol Biol Phys 2010;76: S70–6.
  • Vogelius IR, Bentzen SM. A literature-based meta-analysis of clinical risk factors for development of radiation induced pneumonitis. Acta Oncol 2012;51:975–83.
  • Dang J, Li G, Ma L, Diao R, Zang S, Han C, et al. Predictors of grade >/ = 2 and grade >/ = 3 radiation pneumonitis in patients with locally advanced non-small cell lung cancer treated with three-dimensional conformal radiotherapy. Acta Oncol 2013;52:1175–80.
  • Blom-Goldman U, Svane G, Wennberg B, Lidestahl A, Lind PA. Quantitative assessment of lung density changes after 3-D radiotherapy for breast cancer. Acta Oncol 2007; 46:187–93.
  • Kahan Z, Csenki M, Varga Z, Szil E, Cserhati A, Balogh A, et al. The risk of early and late lung sequelae after conformal radiotherapy in breast cancer patients. Int J Radiat Oncol Biol Phys 2007;68:673–81.
  • Fox AM, Dosoretz AP, Mauch PM, Chen YH, Fisher DC, Lacasce AS, et al. Predictive factors for radiation pneumonitis in hodgkin lymphoma patients receiving combined-modality therapy. Int J Radiat Oncol Biol Phys 2012;83:277–83.
  • Koh ES, Sun A, Tran TH, Tsang R, Pintilie M, Hodgson DC, et al. Clinical dose-volume histogram analysis in predicting radiation pneumonitis in Hodgkin’s lymphoma. Int J Radiat Oncol Biol Phys 2006;66:223–8.
  • Ng AK, Li S, Neuberg D, Chi R, Fisher DC, Silver B, et al. A prospective study of pulmonary function in Hodgkin’s lymphoma patients. Ann Oncol 2008;19:1754–8.
  • Wall RJ, Schnapp LM. Radiation pneumonitis. Respir Care 2006;51:1255–60.
  • Ghobadi G, van der Veen S, Bartelds B, de Boer RA, Dickinson MG, de Jong JR, et al. Physiological interaction of heart and lung in thoracic irradiation. Int J Radiat Oncol Biol Phys 2012;84:e639–46.
  • Maraldo MV, Brodin NP, Aznar MC, Vogelius IR, Munck Af Rosenschold P, Petersen PM, et al. Estimated risk of cardiovascular disease and secondary cancers with modern highly conformal radiotherapy for early-stage mediastinal Hodgkin lymphoma. Ann Oncol 2013;24: 2113–8.
  • Cella L, Liuzzi R, Magliulo M, Conson M, Camera L, Salvatore M, et al. Radiotherapy of large target volumes in Hodgkin’s lymphoma: Normal tissue sparing capability of forward IMRT versus conventional techniques. Radiat Oncol 2010;5:33.
  • Cella L, Conson M, Caterino M, De Rosa N, Liuzzi R, Picardi M, et al. Thyroid V30 predicts radiation-induced hypothyroidism in patients treated with sequential chemo-radiotherapy for Hodgkin’s lymphoma. Int J Radiat Oncol Biol Phys 2012;82:1802–8.
  • Kong FM, Ritter T, Quint DJ, Senan S, Gaspar LE, Komaki RU, et al. Consideration of dose limits for organs at risk of thoracic radiotherapy: Atlas for lung, proximal bronchial tree, esophagus, spinal cord, ribs, and brachial plexus. Int J Radiat Oncol Biol Phys 2011;81:1442–57.
  • Cella L, Liuzzi R, Conson M, Torre G, Caterino M, De Rosa N, et al. Dosimetric predictors of asymptomatic heart valvular dysfunction following mediastinal irradiation for Hodgkin’s lymphoma. Radiother Oncol 2011;101:316–21.
  • Cox JD, Stetz J Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 1995;31:1341–6.
  • Matusiewicz SP, Williamson IJ, Sime PJ, Brown PH, Wenham PR, Crompton GK, et al. Plasma lactate dehydrogenase: A marker of disease activity in cryptogenic fibrosing alveolitis and extrinsic allergic alveolitis?Eur Respir J 1993; 6:1282–6.
  • Rasmussen F, Mikkelsen D, Hancox RJ, Lambrechtsen J, Nybo M, Hansen HS, et al. High-sensitive C-reactive protein is associated with reduced lung function in young adults. Eur Respir J 2009;33:382–8.
  • Sleijfer S. Bleomycin-induced pneumonitis. Chest 2001; 120:617–24.
  • Hirsch A, Vander Els N, Straus DJ, Gomez EG, Leung D, Portlock CS, et al. Effect of ABVD chemotherapy with and without mantle or mediastinal irradiation on pulmonary function and symptoms in early-stage Hodgkin’s disease. J Clin Oncol 1996;14:1297–305.
  • Wiegman EM, Meertens H, Konings AW, Kampinga HH Coppes RP. Loco-regional differences in pulmonary function and density after partial rat lung irradiation. Radiother Oncol 2003;69:11–9.
  • Ramella S, Trodella L, Mineo TC, Pompeo E, Stimato G, Gaudino D, et al. Adding ipsilateral V20 and V30 to conventional dosimetric constraints predicts radiation pneumonitis in stage IIIA-B NSCLC treated with combined-modality therapy. Int J Radiat Oncol Biol Phys 2010;76:110–5.
  • Fay M, Tan A, Fisher R, Mac Manus M, Wirth A Ball D. Dose-volume histogram analysis as predictor of radiation pneumonitis in primary lung cancer patients treated with radiotherapy. Int J Radiat Oncol Biol Phys 2005;61: 1355–63.
  • Huang EX, Hope AJ, Lindsay PE, Trovo M, El Naqa I, Deasy JO, et al. Heart irradiation as a risk factor for radiation pneumonitis. Acta Oncol 2011;50:51–60.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.